CDB-4124 and its putative monodemethylated metabolite, CDB-4453, are potent antiprogestins with reduced antiglucocorticoid activity: in vitro comparison to mifepristone and CDB-2914

Molecular and Cellular Endocrinology
Barbara J AttardiRichard Blye

Abstract

To obtain selective antiprogestins, we have examined the in vitro antiprogestational/antiglucocorticoid properties of two novel compounds, CDB-4124 and the putative monodemethylated metabolite, CDB-4453, in transcription and receptor binding assays and compared them to CDB-2914 and mifepristone. All four antiprogestins bound with high affinity to rabbit uterine progestin receptors (PR) and recombinant human PR-A and PR-B (rhPR-A, rhPR-B) and were potent inhibitors of R5020-induced transactivation of the PRE2-tk-luciferase (PRE2-tk-LUC) reporter plasmid and endogenous alkaline phosphatase production in T47D-CO human breast cancer cells. None of these compounds exhibited agonist activity in these cells. Induction of luciferase activity was potentiated about five-fold by 8-Br-cAMP under basal conditions and to the same extent in the presence of the PR antagonists. Mifepristone bound to rabbit thymic glucocorticoid receptors (GR) with approximately twice the avidity of the CDB antiprogestins. Inhibition of GR-mediated transcription of PRE2-tk-LUC was assessed in HepG2 human hepatoblastoma cells. Mifepristone exhibited greater antiglucocorticoid activity than CDB-2914, 4124, and 4453, about 12-, 22-, and 185-fold, respectively. Thus...Continue Reading

References

Sep 1, 1986·Journal of Steroid Biochemistry·D GagneA Crastes de Paulet
Dec 1, 1987·Experimental Cell Research·N BussoD Belin
Oct 1, 1988·Journal of Steroid Biochemistry·H J KloosterboerH J Loozen
Jun 1, 1994·Human Reproduction·G Teutsch, D Philibert
Jan 1, 1994·The Journal of Steroid Biochemistry and Molecular Biology·L Markiewicz, E Gurpide
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·C A BeckD P Edwards
Jan 1, 1996·Annual Review of Pharmacology and Toxicology·I M SpitzA Robbins
Jan 1, 1997·Annual Review of Medicine·F CadepondE E Baulieu
Jan 11, 2001·Journal of Medicinal Chemistry·U FuhrmannK Chwalisz
Jan 1, 1964·Metabolism: Clinical and Experimental·I RINGLERE W BOLAND
Dec 31, 1934·The Journal of Physiology·M K McPhail

❮ Previous
Next ❯

Citations

Apr 27, 2013·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Carmen A HuniadiFlorin Stamatian
Dec 12, 2003·Steroids·Erin E Gainer, André Ulmann
Jan 13, 2009·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Olga B IoffeGeorge L Mutter
Feb 3, 2012·The New England Journal of Medicine·Jacques DonnezUNKNOWN PEARL II Study Group
Feb 3, 2012·The New England Journal of Medicine·Jacques DonnezUNKNOWN PEARL I Study Group
Jun 29, 2012·Human Reproduction·Laudine CommunalAnne Gompel
Nov 2, 2006·Obstetrics and Gynecology·Mitchell D CreininJames Higgins
Feb 22, 2012·Endocrine-related Cancer·Claudia LanariAlfredo A Molinolo
May 17, 2011·Drugs·Kate McKeage, Jamie D Croxtall
Mar 22, 2014·Pharmacology, Biochemistry, and Behavior·Lynda Uphouse, Cindy Hiegel
Aug 29, 2014·BioMed Research International·Gabriella ZitoGiuseppe Ricci
Dec 17, 2008·Women's Health·Sophie OuzounianNathalie Chabbert-Buffet
Mar 29, 2014·Journal of Enzyme Inhibition and Medicinal Chemistry·Marisa CabezaEugene Bratoeff
Nov 13, 2014·Climacteric : the Journal of the International Menopause Society·F R Pérez-López
Jan 23, 2016·Frontiers in Pharmacology·Elena RosatoCarlo Bastianelli
Nov 28, 2009·The Journal of Steroid Biochemistry and Molecular Biology·Barbara J AttardiAlvin M Matsumoto
Nov 5, 2014·International Journal of Cancer. Journal International Du Cancer·Victoria WargonClaudia Lanari
Sep 25, 2014·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·P CzuczwarT Paszkowski
Jun 12, 2012·Expert Opinion on Drug Metabolism & Toxicology·Gian Benedetto MelisAnna Maria Paoletti
Jan 18, 2011·Expert Opinion on Emerging Drugs·Luis BahamondesIlza Monteiro
Dec 3, 2008·Expert Opinion on Emerging Drugs·Sun-Wei Guo
Dec 7, 2007·American Journal of Obstetrics and Gynecology·Barbara J AttardiUNKNOWN Obstetric-Fetal Pharmacology Research Unit Network
Aug 4, 2009·American Journal of Obstetrics and Gynecology·Nadav SchwartzChristine N Metz
Sep 10, 2008·Expert Opinion on Pharmacotherapy·Giuseppe BenagianoManuela Farris
Nov 26, 2011·Expert Review of Clinical Pharmacology·Jade L Sullivan, Marilyn N Bulloch
Jan 21, 2014·Reproductive Sciences·Bruno MozzanegaGiovanni Battista Nardelli
Jul 9, 2014·Reproductive Sciences·Pasquapina CiarmelaFelice Petraglia
Mar 23, 2011·Reproductive Sciences·Hilary RoederPhyllis C Leppert
Jan 21, 2010·Nuclear Receptor Signaling·Rebecca L RobkerDarryl L Russell
Jan 19, 2019·The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception·Bruno Mozzanega, Giovanni Battista Nardelli
Sep 26, 2007·International Journal of Cancer. Journal International Du Cancer·Joyce C L Leo, Valerie C L Lin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.